Open AccessS353 Time to Clinically Meaningful Improvement in Dysphagia Frequency in Adults with Eosinophilic Esophagitis: A Post-Hoc Analysis From a Phase 2b Trial of APT-1011, a Fluticasone Propionate Oral Disintegrating Tablet
Author(s) -
Gary W. Falk,
Ikuo Hirano,
Alfredo J. Lucendo,
Alain Schoepfer,
Christop Schlag,
Gina Eagle,
James Nezamis,
Gail M. Comer,
Karol Knoop,
Evan S. Dellon
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000773884.45924.08
Subject(s) - medicine , dysphagia , eosinophilic esophagitis , placebo , post hoc analysis , fluticasone propionate , randomized controlled trial , surgery , corticosteroid , disease , pathology , alternative medicine